Cargando…
Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counterregulation in Biobreeding Diabetic Rats
Impaired counterregulation during hypoglycemia in type 1 diabetes (T1D) is partly attributable to inadequate glucagon secretion. Intra-islet somatostatin (SST) suppression of hypoglycemia-stimulated α-cell glucagon release plays an important role. We hypothesized that hypoglycemia can be prevented i...
Autores principales: | Karimian, Negar, Qin, Tairan, Liang, Tao, Osundiji, Mayowa, Huang, Yachi, Teich, Trevor, Riddell, Michael C., Cattral, Mark S., Coy, David H., Vranic, Mladen, Gaisano, Herbert Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717832/ https://www.ncbi.nlm.nih.gov/pubmed/23630299 http://dx.doi.org/10.2337/db13-0164 |
Ejemplares similares
-
Somatostatin Receptor Type 2 Antagonism Improves Glucagon and Corticosterone Counterregulatory Responses to Hypoglycemia in Streptozotocin-Induced Diabetic Rats
por: Yue, Jessica T.Y., et al.
Publicado: (2012) -
Amelioration of Hypoglycemia Via Somatostatin Receptor Type 2 Antagonism in Recurrently Hypoglycemic Diabetic Rats
por: Yue, Jessica T.Y., et al.
Publicado: (2013) -
Glucagon secretion and signaling in the development of diabetes
por: Gaisano, Herbert Y., et al.
Publicado: (2012) -
Association of Basal Hyperglucagonemia with Impaired Glucagon Counterregulation in Type 1 Diabetes
por: Farhy, Leon S., et al.
Publicado: (2012) -
Role of K(ATP) Channels in Glucose-Regulated Glucagon Secretion and Impaired Counterregulation in Type 2 Diabetes
por: Zhang, Quan, et al.
Publicado: (2013)